George Scangos, Ph.D.

George Scangos, Ph.D.

DirectoratVoyager Therapeutics· In proxies 2023–2025

George Scangos, Ph.D. sits on 7 public boards.

Boards1

  • Voyager TherapeuticsDirector · 0 yr on the boardIndependentScience and Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Voyager TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -66%
  2. Rezo Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Octave Bioscience, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  4. Vir Biotechnology, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  5. Agilent Technologies, Inc.Public company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  6. Life Science CaresPublic company
    • Director? – PresentNo stock prices for these years
  7. Global Alliance for TB Drug DevelopmentPublic company · 4 yr
    • Director2006 – 2010 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?